| (+)-alpha-tocopherol | multiple interactions | ISO | RGD:2803 | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] | CTD | PMID:19595682 |
| (+)-alpha-tocopherol | multiple interactions | ISO | RGD:2803 | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in increased activity of HMGCR protein] | CTD | PMID:21535577 |
| (+)-artemisinic acid | multiple interactions | EXP | | 6480464 | [[artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA] which results in decreased chemical synthesis of Cholesterol; more ... | CTD | PMID:23063590 |
| (+)-artemisinic acid | decreases expression | EXP | | 6480464 | [artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA; more ... | CTD | PMID:23063590 |
| (24S)-24-hydroxycholesterol | decreases activity | EXP | | 6480464 | 24-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:7751816 |
| (3S,5R)-fluvastatin | multiple interactions | EXP | | 6480464 | [APOB gene SNP co-treated with APOE gene SNP co-treated with HMGCR gene SNP co-treated with LDLR gene SNP co-treated with PCSK9 gene SNP co-treated with ABCA1 gene SNP co-treated with CETP gene SNP co-treated with LIPC gene SNP co-treated with LPL gene SNP] affects the susceptibility to fluvastatin | CTD | PMID:19773416 |
| (3S,5R)-fluvastatin | decreases activity | EXP | | 6480464 | fluvastatin results in decreased activity of HMGCR protein | CTD | PMID:8593127 |
| (R)-mevalonic acid | multiple interactions | ISO | RGD:2803 | 6480464 | Mevalonic Acid inhibits the reaction [atorvastatin results in increased activity of HMGCR protein]; more ... | CTD | PMID:12056585 |
| (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | [25-hydroxycholesterol co-treated with Mevalonic Acid] results in increased ubiquitination of HMGCR protein | CTD | PMID:21944868 |
| (R)-mevalonic acid | multiple interactions | ISO | RGD:2803 | 6480464 | Mevalonic Acid inhibits the reaction [Clofibrate results in decreased expression of HMGCR mRNA] | CTD | PMID:12518023 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of HMGCR mRNA | CTD | PMID:23416264 |
| 1,2,4-trimethylbenzene | decreases expression | ISO | RGD:2803 | 6480464 | pseudocumene results in decreased expression of HMGCR protein | CTD | PMID:17337753 |
| 17alpha-ethynylestradiol | increases activity | ISO | RGD:2803 | 6480464 | Ethinyl Estradiol results in increased activity of HMGCR protein | CTD | PMID:11473529 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of HMGCR mRNA; more ... | CTD | PMID:16751804 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | ISO | RGD:731580 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of HMGCR mRNA | CTD | PMID:20005886 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HMGCR mRNA | CTD | PMID:20106945 PMID:17101203 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731580 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HMGCR mRNA | CTD | PMID:20005886 PMID:22977169 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HMGCR mRNA | CTD | PMID:17101203 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:2803 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HMGCR mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HMGCR mRNA | CTD | PMID:17101203 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731580 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HMGCR mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731580 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HMGCR mRNA | CTD | PMID:20005886 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:731580 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of HMGCR mRNA | CTD | PMID:17982090 |
| 2,6-di-tert-butyl-4-methylphenol | increases activity | ISO | RGD:2803 | 6480464 | Butylated Hydroxytoluene results in increased activity of HMGCR protein | CTD | PMID:9199277 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:2803 | 6480464 | 2,6-dinitrotoluene affects the expression of HMGCR mRNA | CTD | PMID:21346803 |
| 2-trans,6-trans,10-trans-geranylgeranyl diphosphate | multiple interactions | EXP | | 6480464 | [Lovastatin results in decreased activity of HMGCR protein] which results in decreased abundance of geranylgeranyl pyrophosphate | CTD | PMID:17208200 |
| 2-trans,6-trans-farnesyl diphosphate | multiple interactions | EXP | | 6480464 | [Lovastatin results in decreased activity of HMGCR protein] which results in decreased abundance of farnesyl pyrophosphate | CTD | PMID:17208200 |
| 24,25-dihydrolanosterol | decreases activity | EXP | | 6480464 | lanostenol results in decreased activity of HMGCR protein | CTD | PMID:18024962 |
| 25-hydroxycholesterol | decreases activity | EXP | | 6480464 | 25-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:9059514 more ... |
| 25-hydroxycholesterol | multiple interactions | EXP | | 6480464 | [25-hydroxycholesterol co-treated with Mevalonic Acid] results in increased ubiquitination of HMGCR protein | CTD | PMID:21944868 |
| 25-hydroxycholesterol | decreases activity | EXP | | 6480464 | 25-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:18024962 more ... |
| 25-hydroxycholesterol | decreases activity | EXP | | 6480464 | 25-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:9059514 more ... |
| 25-hydroxycholesterol | decreases activity | ISO | RGD:2803 | 6480464 | 25-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:7749852 |
| 25-hydroxycholesterol | decreases activity | EXP | | 6480464 | 25-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:18024962 more ... |
| 25-hydroxycholesterol | decreases expression | ISO | RGD:731580 | 6480464 | 25-hydroxycholesterol results in decreased expression of HMGCR protein; more ... | CTD | PMID:19260826 |
| 25-hydroxycholesterol | multiple interactions | EXP | | 6480464 | Dehydroepiandrosterone inhibits the reaction [25-hydroxycholesterol results in decreased activity of HMGCR protein]; more ... | CTD | PMID:9059514 |
| 25-hydroxycholesterol | decreases activity | EXP | | 6480464 | 25-hydroxycholesterol metabolite results in decreased activity of HMGCR protein | CTD | PMID:9059514 |
| 25-hydroxycholesterol | decreases activity | EXP | | 6480464 | 25-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:7749852 more ... |
| 25-hydroxycholesterol | decreases activity | EXP | | 6480464 | 25-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:7749852 more ... |
| 25-hydroxycholesterol | decreases activity | EXP | | 6480464 | 25-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:7749852 more ... |
| 26-hydroxycholesterol | decreases activity | ISO | RGD:2803 | 6480464 | 27-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:7749852 PMID:7788503 |
| 26-hydroxycholesterol | decreases activity | EXP | | 6480464 | 27-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:7751816 more ... |
| 26-hydroxycholesterol | decreases activity | EXP | | 6480464 | 27-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:9059514 more ... |
| 26-hydroxycholesterol | decreases activity | EXP | | 6480464 | 27-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:9059514 more ... |
| 26-hydroxycholesterol | decreases activity | ISO | RGD:2803 | 6480464 | 27-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:7788503 PMID:7749852 |
| 26-hydroxycholesterol | decreases activity | EXP | | 6480464 | 27-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:7751816 more ... |
| 26-hydroxycholesterol | decreases activity | EXP | | 6480464 | 27-hydroxycholesterol metabolite results in decreased activity of HMGCR protein | CTD | PMID:9059514 |
| 26-hydroxycholesterol | multiple interactions | EXP | | 6480464 | Dehydroepiandrosterone inhibits the reaction [27-hydroxycholesterol results in decreased activity of HMGCR protein]; more ... | CTD | PMID:9059514 |
| 26-hydroxycholesterol | multiple interactions | EXP | | 6480464 | [[CYP27A1 protein results in increased metabolism of Cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol] which results in increased activity of HMGCR protein | CTD | PMID:11408283 |
| 26-hydroxycholesterol | decreases activity | EXP | | 6480464 | 27-hydroxycholesterol results in decreased activity of HMGCR protein | CTD | PMID:18024962 more ... |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases activity | ISO | RGD:2803 | 6480464 | Puromycin Aminonucleoside results in increased activity of HMGCR protein | CTD | PMID:3794548 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:731580 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of HMGCR mRNA | CTD | PMID:16054899 |
| 3beta-hydroxy-5alpha-cholest-8(14)-en-15-one | decreases activity | EXP | | 6480464 | cholest-8(14)-en-3-ol-15-one results in decreased activity of HMGCR protein | CTD | PMID:7751816 |
| 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:2803 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of HMGCR mRNA | CTD | PMID:19162173 |
| 4-coumaric acid | decreases expression | ISO | RGD:731580 | 6480464 | 4-coumaric acid results in decreased expression of HMGCR mRNA | CTD | PMID:21870829 |
| 7-ketocholesterol | decreases activity | EXP | | 6480464 | 7-ketocholesterol results in decreased activity of HMGCR protein | CTD | PMID:7751816 |
| 7alpha-hydroxycholesterol | decreases activity | ISO | RGD:2803 | 6480464 | cholest-5-en-3 beta,7 alpha-diol results in decreased activity of HMGCR protein | CTD | PMID:9199277 |
| aflatoxin B1 | decreases expression | ISO | RGD:731580 | 6480464 | Aflatoxin B1 results in decreased expression of HMGCR mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of HMGCR mRNA | CTD | PMID:21641981 |
| ammonium chloride | affects expression | ISO | RGD:2803 | 6480464 | Ammonium Chloride affects the expression of HMGCR mRNA | CTD | PMID:16483693 |
| arachidonic acid | decreases expression | EXP | | 6480464 | Arachidonic Acid results in decreased expression of HMGCR mRNA | CTD | PMID:16704987 |
| Aroclor 1254 | increases expression | ISO | RGD:2803 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of HMGCR mRNA | CTD | PMID:18178546 |
| benzene | affects expression | ISO | RGD:2803 | 6480464 | Benzene affects the expression of HMGCR mRNA | CTD | PMID:15878777 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of HMGCR mRNA | CTD | PMID:20064835 PMID:20106945 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of HMGCR mRNA | CTD | PMID:16269432 more ... |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HMGCR mRNA; more ... | CTD | PMID:17690111 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of HMGCR mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:2803 | 6480464 | Benzo(a)pyrene results in decreased expression of HMGCR protein; more ... | CTD | PMID:19931295 |
| benzo[a]pyrene | increases expression | ISO | RGD:731580 | 6480464 | Benzo(a)pyrene results in increased expression of HMGCR mRNA | CTD | PMID:19770486 PMID:21569818 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:2803 | 6480464 | Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in decreased expression of HMGCR mRNA]; more ... | CTD | PMID:19931295 |
| benzo[a]pyrene | increases expression | ISO | RGD:731580 | 6480464 | Benzo(a)pyrene results in increased expression of HMGCR mRNA | CTD | PMID:21569818 PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731580 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of HMGCR mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of HMGCR mRNA | CTD | PMID:20106945 PMID:20064835 |
| benzo[a]pyrene | increases expression | ISO | RGD:731580 | 6480464 | Benzo(a)pyrene results in increased expression of HMGCR mRNA | CTD | PMID:19770486 |
| benzo[b]fluoranthene | decreases expression | EXP | | 6480464 | benzo(b)fluoranthene results in decreased expression of HMGCR mRNA | CTD | PMID:16269432 |
| benzo[b]fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of HMGCR mRNA | CTD | PMID:17690111 |
| bezafibrate | decreases activity | ISO | RGD:2803 | 6480464 | Bezafibrate results in decreased activity of HMGCR protein | CTD | PMID:2044640 PMID:2907502 |
| bezafibrate | decreases activity | ISO | RGD:2803 | 6480464 | Bezafibrate results in decreased activity of HMGCR protein | CTD | PMID:2907502 PMID:2044640 |
| bezafibrate | increases activity | EXP | | 6480464 | Bezafibrate results in increased activity of HMGCR protein | CTD | PMID:2044640 |
| bilirubin | multiple interactions | ISO | RGD:2803 | 6480464 | [Manganese co-treated with Bilirubin] results in decreased activity of HMGCR protein | CTD | PMID:12700418 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:731580 | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of HMGCR mRNA] | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:2803 | 6480464 | [Clofibrate co-treated with Diethylhexyl Phthalate] results in decreased expression of HMGCR mRNA | CTD | PMID:9207284 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:731580 | 6480464 | Diethylhexyl Phthalate results in increased expression of HMGCR mRNA | CTD | PMID:19850644 |
| bisphenol A | increases expression | ISO | RGD:731580 | 6480464 | bisphenol A results in increased expression of HMGCR mRNA | CTD | PMID:21932408 |
| cadmium atom | increases expression | ISO | RGD:2803 | 6480464 | Cadmium results in increased expression of HMGCR mRNA | CTD | PMID:17066326 |
| cadmium atom | multiple interactions | ISO | RGD:2803 | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in increased activity of HMGCR protein] | CTD | PMID:21535577 |
| cadmium atom | increases activity | ISO | RGD:2803 | 6480464 | Cadmium results in increased activity of HMGCR protein | CTD | PMID:21535577 |
| cadmium dichloride | increases expression | ISO | RGD:2803 | 6480464 | Cadmium Chloride results in increased expression of HMGCR mRNA | CTD | PMID:17066326 |
| cadmium dichloride | increases expression | ISO | RGD:2803 | 6480464 | Cadmium Chloride results in increased expression of HMGCR mRNA | CTD | PMID:17066326 PMID:19010381 |
| cadmium dichloride | increases expression | ISO | RGD:2803 | 6480464 | Cadmium Chloride results in increased expression of HMGCR mRNA | CTD | PMID:19010381 PMID:17066326 |
| cadmium sulfate | multiple interactions | EXP | | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of HMGCR mRNA | CTD | PMID:18654764 |
| carbamazepine | decreases expression | EXP | | 6480464 | Carbamazepine results in decreased expression of HMGCR mRNA | CTD | PMID:19566492 |
| chenodeoxycholic acid | decreases response to substance | EXP | | 6480464 | HMGCR protein results in decreased susceptibility to Chenodeoxycholic Acid | CTD | PMID:7461467 |
| chlorogenic acid | decreases expression | ISO | RGD:731580 | 6480464 | Chlorogenic Acid results in decreased expression of HMGCR mRNA | CTD | PMID:21870829 |
| chlorogenic acid | multiple interactions | ISO | RGD:2803 | 6480464 | Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in increased activity of HMGCR protein]; more ... | CTD | PMID:20696151 |
| chlorpromazine | increases expression | EXP | | 6480464 | Chlorpromazine results in increased expression of HMGCR mRNA | CTD | PMID:17052361 |
| cholesterol | multiple interactions | ISO | RGD:2803 | 6480464 | Selenium promotes the reaction [Cholesterol results in decreased expression of HMGCR mRNA] | CTD | PMID:16581047 |
| cholesterol | multiple interactions | EXP | | 6480464 | [[artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA] which results in decreased chemical synthesis of Cholesterol; more ... | CTD | PMID:23063590 |
| cholesterol | multiple interactions | ISO | RGD:2803 | 6480464 | [turmeric extract co-treated with Cholesterol] results in decreased expression of HMGCR mRNA | CTD | PMID:21535835 |
| cholesterol | decreases expression | ISO | RGD:2803 | 6480464 | Cholesterol results in decreased expression of HMGCR mRNA | CTD | PMID:16581047 |
| cholesterol | multiple interactions | EXP | | 6480464 | [[CYP27A1 protein results in increased metabolism of Cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol] which results in increased activity of HMGCR protein | CTD | PMID:11408283 |
| cholesterol | multiple interactions | EXP | | 6480464 | [Clozapine results in increased activity of HMGCR protein] which results in increased abundance of Cholesterol; more ... | CTD | PMID:16027736 |
| cholesterol | decreases expression | EXP | | 6480464 | Cholesterol results in decreased expression of HMGCR mRNA | CTD | PMID:17516993 |
| cholesterol | decreases activity | EXP | | 6480464 | Cholesterol results in decreased activity of HMGCR protein | CTD | PMID:18024962 |
| choline | multiple interactions | ISO | RGD:731580 | 6480464 | RXRA gene mutant form promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of HMGCR mRNA] | CTD | PMID:18952117 |
| choline | multiple interactions | ISO | RGD:731580 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HMGCR mRNA | CTD | PMID:20938992 |
| chromium atom | decreases expression | EXP | | 6480464 | Chromium results in decreased expression of HMGCR mRNA | CTD | PMID:17547211 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:731580 | 6480464 | Ciguatoxins affects the expression of HMGCR mRNA | CTD | PMID:18353800 |
| cinnamic acid | decreases expression | ISO | RGD:731580 | 6480464 | cinnamic acid results in decreased expression of HMGCR mRNA | CTD | PMID:21870829 |
| cis-caffeic acid | decreases expression | ISO | RGD:731580 | 6480464 | caffeic acid results in decreased expression of HMGCR mRNA | CTD | PMID:21870829 |
| cis-ketoconazole | increases activity | ISO | RGD:2803 | 6480464 | Ketoconazole results in increased activity of HMGCR protein | CTD | PMID:9199277 |
| clofibrate | decreases activity | ISO | RGD:731580 | 6480464 | Clofibrate results in decreased activity of HMGCR protein | CTD | PMID:18611391 |
| clofibrate | decreases expression | ISO | RGD:2803 | 6480464 | Clofibrate results in decreased expression of HMGCR mRNA | CTD | PMID:12518023 more ... |
| clofibrate | decreases expression | ISO | RGD:2803 | 6480464 | Clofibrate results in decreased expression of HMGCR mRNA | CTD | PMID:17126302 more ... |
| clofibrate | multiple interactions | ISO | RGD:2803 | 6480464 | [Clofibrate co-treated with Diethylhexyl Phthalate] results in decreased expression of HMGCR mRNA | CTD | PMID:9207284 |
| clofibrate | decreases expression | ISO | RGD:731580 | 6480464 | Clofibrate results in decreased expression of HMGCR protein | CTD | PMID:20573577 |
| clofibrate | decreases expression | ISO | RGD:2803 | 6480464 | Clofibrate results in decreased expression of HMGCR mRNA | CTD | PMID:17126302 more ... |
| clofibrate | decreases expression | ISO | RGD:2803 | 6480464 | Clofibrate results in decreased expression of HMGCR mRNA | CTD | PMID:12518023 PMID:17126302 |
| clofibrate | multiple interactions | ISO | RGD:2803 | 6480464 | Mevalonic Acid inhibits the reaction [Clofibrate results in decreased expression of HMGCR mRNA] | CTD | PMID:12518023 |
| clofibrate | decreases expression | ISO | RGD:2803 | 6480464 | Clofibrate results in decreased expression of HMGCR mRNA | CTD | PMID:17126302 PMID:12518023 |
| clofibrate | decreases activity | ISO | RGD:2803 | 6480464 | Clofibrate results in decreased activity of HMGCR protein | CTD | PMID:1327145 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of HMGCR | CTD | PMID:16502264 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of HMGCR mRNA | CTD | PMID:17052361 PMID:16027736 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of HMGCR mRNA | CTD | PMID:16027736 PMID:17052361 |
| clozapine | increases activity | EXP | | 6480464 | Clozapine results in increased activity of HMGCR protein | CTD | PMID:16027736 |
| clozapine | multiple interactions | EXP | | 6480464 | [Clozapine results in increased activity of HMGCR protein] which results in increased abundance of Triglycerides; more ... | CTD | PMID:16027736 |
| cobalt dichloride | multiple interactions | EXP | | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of HMGCR mRNA | CTD | PMID:18654764 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of HMGCR mRNA | CTD | PMID:19376846 |
| colesevelam hydrochloride | multiple interactions | ISO | RGD:731580 | 6480464 | colesevelam promotes the reaction [Simvastatin results in increased expression of HMGCR mRNA] | CTD | PMID:22120639 |
| colesevelam hydrochloride | increases expression | ISO | RGD:731580 | 6480464 | colesevelam results in increased expression of HMGCR mRNA | CTD | PMID:22120639 |
| copper atom | increases expression | ISO | RGD:2803 | 6480464 | Copper results in increased expression of HMGCR mRNA | CTD | PMID:22465980 |
| copper atom | decreases expression | ISO | RGD:731580 | 6480464 | Copper results in decreased expression of HMGCR mRNA | CTD | PMID:17205981 |
| copper(0) | increases expression | ISO | RGD:2803 | 6480464 | Copper results in increased expression of HMGCR mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | ISO | RGD:731580 | 6480464 | Copper results in decreased expression of HMGCR mRNA | CTD | PMID:17205981 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of HMGCR mRNA | CTD | PMID:19549813 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of HMGCR mRNA | CTD | PMID:12860252 |
| coumarin | increases expression | ISO | RGD:2803 | 6480464 | coumarin results in increased expression of HMGCR mRNA | CTD | PMID:18480146 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of HMGCR mRNA | CTD | PMID:16713233 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of HMGCR mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of HMGCR mRNA | CTD | PMID:20106945 PMID:21632981 |
| cyclosporin A | decreases expression | ISO | RGD:2803 | 6480464 | Cyclosporine results in decreased expression of HMGCR mRNA | CTD | PMID:19224547 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of HMGCR mRNA | CTD | PMID:17516993 |
| dehydroepiandrosterone | multiple interactions | EXP | | 6480464 | Dehydroepiandrosterone inhibits the reaction [25-hydroxycholesterol results in decreased activity of HMGCR protein]; more ... | CTD | PMID:9059514 |
| desmosterol | decreases expression | ISO | RGD:731580 | 6480464 | Desmosterol results in decreased expression of HMGCR protein | CTD | PMID:19260826 |
| dexamethasone | multiple interactions | ISO | RGD:731580 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of HMGCR mRNA | CTD | PMID:16054899 |
| dexamethasone | increases expression | ISO | RGD:2803 | 6480464 | Dexamethasone results in increased expression of HMGCR mRNA | CTD | PMID:16962226 |
| diazoxide | multiple interactions | ISO | RGD:2803 | 6480464 | alliin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] | CTD | PMID:16640830 |
| diazoxide | increases activity | ISO | RGD:2803 | 6480464 | Isoproterenol results in increased activity of HMGCR protein | CTD | PMID:19595682 more ... |
| diazoxide | increases activity | ISO | RGD:2803 | 6480464 | Isoproterenol results in increased activity of HMGCR protein | CTD | PMID:16906524 more ... |
| diazoxide | increases activity | ISO | RGD:2803 | 6480464 | Isoproterenol results in increased activity of HMGCR protein | CTD | PMID:16640830 more ... |
| diazoxide | multiple interactions | ISO | RGD:2803 | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] | CTD | PMID:19595682 |
| diazoxide | multiple interactions | ISO | RGD:2803 | 6480464 | naringin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] | CTD | PMID:16906524 |
| diazoxide | increases activity | ISO | RGD:2803 | 6480464 | Isoproterenol results in increased activity of HMGCR protein | CTD | PMID:16906524 more ... |
| dibenz[a,h]anthracene | decreases expression | EXP | | 6480464 | 1,2,5,6-dibenzanthracene results in decreased expression of HMGCR mRNA | CTD | PMID:16269432 |
| dibenz[a,h]anthracene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HMGCR mRNA | CTD | PMID:17690111 |
| dibenzo[a,l]pyrene | decreases expression | EXP | | 6480464 | dibenzo(a,l)pyrene results in decreased expression of HMGCR mRNA | CTD | PMID:16269432 |
| dibutyl phthalate | decreases expression | ISO | RGD:2803 | 6480464 | Dibutyl Phthalate results in decreased expression of HMGCR mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:2803 | 6480464 | Dibutyl Phthalate results in decreased expression of HMGCR mRNA | CTD | PMID:17379624 PMID:21266533 |
| elemental selenium | multiple interactions | ISO | RGD:2803 | 6480464 | Selenium promotes the reaction [Cholesterol results in decreased expression of HMGCR mRNA] | CTD | PMID:16581047 |
| ethanol | increases expression | ISO | RGD:731580 | 6480464 | Ethanol results in increased expression of HMGCR mRNA | CTD | PMID:19167417 |
| ethanol | decreases activity | EXP | | 6480464 | Ethanol results in decreased activity of HMGCR protein | CTD | PMID:22841563 |
| eugenol | decreases expression | ISO | RGD:731580 | 6480464 | Eugenol results in decreased expression of HMGCR mRNA | CTD | PMID:21870829 |
| ezetimibe | increases activity | EXP | | 6480464 | ezetimibe results in increased activity of HMGCR protein | CTD | PMID:17980884 |
| ezetimibe | multiple interactions | EXP | | 6480464 | [Simvastatin co-treated with ezetimibe] results in increased expression of HMGCR mRNA | CTD | PMID:17980884 |
| farnesyl diphosphate | multiple interactions | EXP | | 6480464 | [Lovastatin results in decreased activity of HMGCR protein] which results in decreased abundance of farnesyl pyrophosphate | CTD | PMID:17208200 |
| ferulic acid | decreases expression | ISO | RGD:731580 | 6480464 | ferulic acid results in decreased expression of HMGCR mRNA | CTD | PMID:21870829 |
| folic acid | multiple interactions | ISO | RGD:731580 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HMGCR mRNA | CTD | PMID:20938992 |
| fructose | increases expression | ISO | RGD:2803 | 6480464 | Fructose results in increased expression of HMGCR mRNA | CTD | PMID:19193814 |
| fructose | multiple interactions | ISO | RGD:2803 | 6480464 | [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased activity of SIRT1 protein] inhibits the reaction [Fructose results in increased expression of HMGCR mRNA]; more ... | CTD | PMID:21212096 |
| fructose | increases expression | ISO | RGD:2803 | 6480464 | Fructose results in increased expression of HMGCR mRNA | CTD | PMID:19193814 PMID:21212096 |
| fructose | multiple interactions | ISO | RGD:2803 | 6480464 | Tea inhibits the reaction [Fructose results in increased expression of HMGCR mRNA] | CTD | PMID:19193814 |
| fucoxanthin | decreases activity | ISO | RGD:731580 | 6480464 | fucoxanthin results in decreased activity of HMGCR protein | CTD | PMID:20519145 |
| furan | increases methylation | ISO | RGD:2803 | 6480464 | furan results in increased methylation of HMGCR gene | CTD | PMID:22079235 |
| geranyl diphosphate | multiple interactions | EXP | | 6480464 | [geranylgeraniol co-treated with geranyl pyrophosphate] results in decreased expression of HMGCR protein | CTD | PMID:19819230 |
| geranylgeraniol | multiple interactions | EXP | | 6480464 | [geranylgeraniol co-treated with geranyl pyrophosphate] results in decreased expression of HMGCR protein | CTD | PMID:19819230 |
| glutathione | increases expression | ISO | RGD:2803 | 6480464 | Glutathione deficiency results in increased expression of HMGCR mRNA | CTD | PMID:15345336 |
| haloperidol | increases activity | EXP | | 6480464 | Haloperidol results in increased activity of HMGCR protein | CTD | PMID:16027736 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of HMGCR mRNA | CTD | PMID:17052361 PMID:16027736 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of HMGCR mRNA | CTD | PMID:16027736 PMID:17052361 |
| haloperidol | multiple interactions | EXP | | 6480464 | [Haloperidol results in increased activity of HMGCR protein] which results in increased abundance of Cholesterol; more ... | CTD | PMID:16027736 |
| heptadecafluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of HMGCR mRNA | CTD | PMID:21641976 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of HMGCR mRNA | CTD | PMID:12414654 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCR mRNA | CTD | PMID:18032389 |
| isoprenaline | increases activity | ISO | RGD:2803 | 6480464 | Isoproterenol results in increased activity of HMGCR protein | CTD | PMID:16906524 more ... |
| isoprenaline | increases activity | ISO | RGD:2803 | 6480464 | Isoproterenol results in increased activity of HMGCR protein | CTD | PMID:16640830 more ... |
| isoprenaline | increases activity | ISO | RGD:2803 | 6480464 | Isoproterenol results in increased activity of HMGCR protein | CTD | PMID:19595682 more ... |
| isoprenaline | multiple interactions | ISO | RGD:2803 | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] | CTD | PMID:19595682 |
| isoprenaline | multiple interactions | ISO | RGD:2803 | 6480464 | naringin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] | CTD | PMID:16906524 |
| isoprenaline | multiple interactions | ISO | RGD:2803 | 6480464 | alliin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] | CTD | PMID:16640830 |
| isotretinoin | decreases expression | EXP | | 6480464 | Isotretinoin results in decreased expression of HMGCR mRNA | CTD | PMID:20436886 |
| ketamine | decreases expression | ISO | RGD:2803 | 6480464 | Ketamine results in decreased expression of HMGCR mRNA | CTD | PMID:20080153 |
| L-methionine | multiple interactions | ISO | RGD:731580 | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in increased expression of HMGCR mRNA; more ... | CTD | PMID:18952117 |
| L-methionine | multiple interactions | ISO | RGD:731580 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HMGCR mRNA | CTD | PMID:20938992 |
| lead(0) | multiple interactions | ISO | RGD:2803 | 6480464 | puerarin affects the reaction [Lead affects the expression of HMGCR] | CTD | PMID:22001170 |
| lead(0) | affects expression | ISO | RGD:2803 | 6480464 | Lead affects the expression of HMGCR | CTD | PMID:22001170 |
| linalool | decreases expression | ISO | RGD:731580 | 6480464 | linalool results in decreased expression of HMGCR mRNA; more ... | CTD | PMID:21944868 |
| linalool | decreases expression | EXP | | 6480464 | linalool results in decreased expression of HMGCR mRNA | CTD | PMID:21944868 |
| linalool | multiple interactions | EXP | | 6480464 | linalool inhibits the reaction [SREBP2 protein binds to HMGCR promoter]; more ... | CTD | PMID:21944868 |
| lithocholic acid | multiple interactions | ISO | RGD:731580 | 6480464 | [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in increased expression of HMGCR mRNA | CTD | PMID:20359477 |
| losartan | multiple interactions | ISO | RGD:2803 | 6480464 | Losartan inhibits the reaction [AGT protein results in increased expression of HMGCR mRNA] | CTD | PMID:19109942 |
| lovastatin | decreases activity | EXP | | 6480464 | Lovastatin results in decreased activity of HMGCR protein | CTD | PMID:17208200 PMID:19699819 |
| lovastatin | decreases activity | EXP | | 6480464 | Lovastatin results in decreased activity of HMGCR protein | CTD | PMID:19699819 more ... |
| lovastatin | decreases activity | EXP | | 6480464 | Lovastatin results in decreased activity of HMGCR protein | CTD | PMID:17208200 more ... |
| lovastatin | increases expression | EXP | | 6480464 | Lovastatin results in increased expression of HMGCR mRNA | CTD | PMID:19260826 PMID:8517861 |
| lovastatin | decreases activity | EXP | | 6480464 | Lovastatin results in decreased activity of HMGCR protein | CTD | PMID:17208200 more ... |
| lovastatin | increases expression | EXP | | 6480464 | Lovastatin results in increased expression of HMGCR mRNA | CTD | PMID:8517861 PMID:19260826 |
| lovastatin | decreases activity | EXP | | 6480464 | Lovastatin results in decreased activity of HMGCR protein | CTD | PMID:19699819 PMID:17208200 |
| lovastatin | increases expression | ISO | RGD:731580 | 6480464 | Lovastatin results in increased expression of HMGCR mRNA | CTD | PMID:19260826 |
| lovastatin | increases expression | EXP | | 6480464 | Lovastatin results in increased expression of HMGCR mRNA | CTD | PMID:19260826 |
| lovastatin | multiple interactions | EXP | | 6480464 | [Lovastatin results in decreased activity of HMGCR protein] which results in decreased abundance of farnesyl pyrophosphate; more ... | CTD | PMID:17208200 |
| lovastatin | multiple interactions | EXP | | 6480464 | Lovastatin inhibits the reaction [HMGCR protein results in increased abundance of geranyl diphosphate] | CTD | PMID:19856009 |
| m-xylene | decreases expression | ISO | RGD:2803 | 6480464 | 3-xylene results in decreased expression of HMGCR mRNA | CTD | PMID:12815608 |
| manganese atom | multiple interactions | ISO | RGD:2803 | 6480464 | [Manganese co-treated with Bilirubin] results in decreased activity of HMGCR protein | CTD | PMID:12700418 |
| manganese atom | increases activity | ISO | RGD:2803 | 6480464 | Manganese results in increased activity of HMGCR protein | CTD | PMID:12700418 |
| manganese(0) | multiple interactions | ISO | RGD:2803 | 6480464 | [Manganese co-treated with Bilirubin] results in decreased activity of HMGCR protein | CTD | PMID:12700418 |
| manganese(0) | increases activity | ISO | RGD:2803 | 6480464 | Manganese results in increased activity of HMGCR protein | CTD | PMID:12700418 |
| menadione | increases expression | EXP | | 6480464 | Vitamin K 3 results in increased expression of HMGCR mRNA | CTD | PMID:12414654 |
| metformin | decreases expression | ISO | RGD:731580 | 6480464 | Metformin results in decreased expression of HMGCR mRNA | CTD | PMID:21870829 |
| mevalonic acid | multiple interactions | ISO | RGD:2803 | 6480464 | Mevalonic Acid inhibits the reaction [Clofibrate results in decreased expression of HMGCR mRNA] | CTD | PMID:12518023 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | [25-hydroxycholesterol co-treated with Mevalonic Acid] results in increased ubiquitination of HMGCR protein | CTD | PMID:21944868 |
| mevalonic acid | multiple interactions | ISO | RGD:2803 | 6480464 | Mevalonic Acid inhibits the reaction [atorvastatin results in increased activity of HMGCR protein]; more ... | CTD | PMID:12056585 |
| mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of HMGCR mRNA | CTD | PMID:23118965 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:2803 | 6480464 | Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in decreased expression of HMGCR mRNA] | CTD | PMID:19931295 |
| N-methylformamide | affects expression | ISO | RGD:731580 | 6480464 | methylformamide affects the expression of HMGCR mRNA; more ... | CTD | PMID:17040096 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2803 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HMGCR mRNA | CTD | PMID:18164116 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of HMGCR mRNA | CTD | PMID:17547211 |
| naringin | multiple interactions | ISO | RGD:2803 | 6480464 | naringin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] | CTD | PMID:16906524 |
| nickel dichloride | decreases expression | EXP | | 6480464 | nickel chloride results in decreased expression of HMGCR mRNA | CTD | PMID:17312168 |
| nicotinamide | multiple interactions | ISO | RGD:2803 | 6480464 | Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in increased activity of HMGCR protein]; more ... | CTD | PMID:20696151 |
| nicotinamide | multiple interactions | ISO | RGD:2803 | 6480464 | [Niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [Fructose results in increased expression of HMGCR mRNA] | CTD | PMID:21212096 |
| olanzapine | increases expression | EXP | | 6480464 | olanzapine results in increased expression of HMGCR mRNA | CTD | PMID:17052361 |
| olanzapine | decreases expression | ISO | RGD:2803 | 6480464 | olanzapine results in decreased expression of HMGCR mRNA | CTD | PMID:23226405 |
| olanzapine | multiple interactions | ISO | RGD:2803 | 6480464 | 1-(carboxymethylthio)tetradecane promotes the reaction [olanzapine results in decreased expression of HMGCR mRNA]; more ... | CTD | PMID:23226405 |
| paracetamol | affects expression | ISO | RGD:731580 | 6480464 | Acetaminophen affects the expression of HMGCR mRNA | CTD | PMID:15030884 PMID:17562736 |
| paracetamol | affects expression | ISO | RGD:731580 | 6480464 | Acetaminophen affects the expression of HMGCR mRNA | CTD | PMID:17562736 PMID:15030884 |
| paracetamol | decreases expression | ISO | RGD:2803 | 6480464 | Acetaminophen results in decreased expression of HMGCR mRNA | CTD | PMID:18246545 |
| paracetamol | increases expression | ISO | RGD:2803 | 6480464 | Acetaminophen results in increased expression of HMGCR mRNA | CTD | PMID:17202762 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:731580 | 6480464 | perfluorooctane sulfonic acid results in increased expression of HMGCR mRNA | CTD | PMID:19429403 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:731580 | 6480464 | perfluorooctane sulfonic acid results in increased expression of HMGCR mRNA | CTD | PMID:19429403 PMID:20936131 |
| perfluorooctane-1-sulfonic acid | decreases activity | ISO | RGD:2803 | 6480464 | perfluorooctane sulfonic acid results in decreased activity of HMGCR protein | CTD | PMID:1327145 |
| perfluorooctanoic acid | increases expression | ISO | RGD:731580 | 6480464 | perfluorooctanoic acid results in increased expression of HMGCR mRNA | CTD | PMID:19429403 |
| perfluorooctanoic acid | increases expression | ISO | RGD:2803 | 6480464 | perfluorooctanoic acid results in increased expression of HMGCR mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases activity | ISO | RGD:2803 | 6480464 | perfluorooctanoic acid results in decreased activity of HMGCR protein | CTD | PMID:1327145 |
| permethrin | decreases expression | ISO | RGD:731580 | 6480464 | Permethrin analog results in decreased expression of HMGCR mRNA | CTD | PMID:21745691 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of HMGCR mRNA | CTD | PMID:12044893 |
| phorone | affects expression | ISO | RGD:2803 | 6480464 | phorone affects the expression of HMGCR mRNA | CTD | PMID:18198479 |
| pioglitazone | increases expression | EXP | | 6480464 | pioglitazone results in increased expression of HMGCR mRNA | CTD | PMID:12044893 |
| pioglitazone | decreases expression | ISO | RGD:731580 | 6480464 | pioglitazone results in decreased expression of HMGCR mRNA | CTD | PMID:20503262 |
| pirinixic acid | multiple interactions | ISO | RGD:731580 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HMGCR mRNA | CTD | PMID:19710929 |
| pirinixic acid | decreases expression | ISO | RGD:731580 | 6480464 | pirinixic acid results in decreased expression of HMGCR mRNA | CTD | PMID:18445702 PMID:15777286 |
| pirinixic acid | decreases expression | ISO | RGD:2803 | 6480464 | pirinixic acid results in decreased expression of HMGCR mRNA | CTD | PMID:17126302 |
| pirinixic acid | decreases expression | ISO | RGD:731580 | 6480464 | pirinixic acid results in decreased expression of HMGCR mRNA | CTD | PMID:15777286 PMID:18445702 |
| piroxicam | decreases expression | EXP | | 6480464 | Piroxicam results in decreased expression of HMGCR mRNA | CTD | PMID:21858171 |
| potassium dichromate | decreases expression | EXP | | 6480464 | Potassium Dichromate results in decreased expression of HMGCR mRNA | CTD | PMID:17547211 |
| pravastatin | decreases response to substance | EXP | | 6480464 | HMGCR gene SNP results in decreased susceptibility to Pravastatin | CTD | PMID:15199031 |
| pravastatin | decreases activity | EXP | | 6480464 | Pravastatin results in decreased activity of HMGCR protein | CTD | PMID:8593127 |
| pravastatin | affects expression | EXP | | 6480464 | Pravastatin affects the expression of HMGCR mRNA | CTD | PMID:8517861 |
| pregnenolone | multiple interactions | EXP | | 6480464 | Pregnenolone inhibits the reaction [25-hydroxycholesterol results in decreased activity of HMGCR protein]; more ... | CTD | PMID:9059514 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:731580 | 6480464 | NR1I2 protein promotes the reaction [Pregnenolone Carbonitrile results in increased expression of HMGCR mRNA] | CTD | PMID:22698814 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:731580 | 6480464 | Pregnenolone Carbonitrile results in increased expression of HMGCR mRNA | CTD | PMID:20359477 PMID:22698814 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:731580 | 6480464 | [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in increased expression of HMGCR mRNA | CTD | PMID:20359477 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:731580 | 6480464 | Pregnenolone Carbonitrile results in increased expression of HMGCR mRNA | CTD | PMID:22698814 |
| progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of HMGCR mRNA | CTD | PMID:18070364 |
| quercetin | multiple interactions | ISO | RGD:2803 | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] | CTD | PMID:19595682 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of HMGCR mRNA | CTD | PMID:21632981 |
| quercetin | multiple interactions | ISO | RGD:2803 | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in increased activity of HMGCR protein] | CTD | PMID:21535577 |
| quercetin 3-O-beta-D-glucoside | multiple interactions | EXP | | 6480464 | [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCR mRNA | CTD | PMID:18032389 |
| quinolin-8-ol | decreases expression | EXP | | 6480464 | Oxyquinoline results in decreased expression of HMGCR mRNA | CTD | PMID:21632981 |
| rel-(3R,5S)-fluvastatin | multiple interactions | EXP | | 6480464 | [APOB gene SNP co-treated with APOE gene SNP co-treated with HMGCR gene SNP co-treated with LDLR gene SNP co-treated with PCSK9 gene SNP co-treated with ABCA1 gene SNP co-treated with CETP gene SNP co-treated with LIPC gene SNP co-treated with LPL gene SNP] affects the susceptibility to fluvastatin | CTD | PMID:19773416 |
| rel-(3R,5S)-fluvastatin | decreases activity | EXP | | 6480464 | fluvastatin results in decreased activity of HMGCR protein | CTD | PMID:8593127 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of HMGCR mRNA | CTD | PMID:22153697 |
| resveratrol | decreases expression | ISO | RGD:2803 | 6480464 | resveratrol results in decreased expression of HMGCR mRNA | CTD | PMID:21907337 |
| resveratrol | multiple interactions | ISO | RGD:2803 | 6480464 | resveratrol inhibits the reaction [Simvastatin results in increased expression of HMGCR mRNA]; more ... | CTD | PMID:21907337 |
| resveratrol | decreases activity | ISO | RGD:731580 | 6480464 | resveratrol results in decreased activity of HMGCR protein | CTD | PMID:18611391 |
| risperidone | increases expression | EXP | | 6480464 | Risperidone results in increased expression of HMGCR mRNA | CTD | PMID:17052361 |
| rosiglitazone | multiple interactions | ISO | RGD:731580 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of HMGCR mRNA | CTD | PMID:16054899 |
| rosiglitazone | increases expression | ISO | RGD:2803 | 6480464 | rosiglitazone results in increased expression of HMGCR mRNA | CTD | PMID:21515302 |
| rosiglitazone | decreases expression | ISO | RGD:731580 | 6480464 | rosiglitazone results in decreased expression of HMGCR mRNA | CTD | PMID:20503262 |
| rotenone | multiple interactions | ISO | RGD:2803 | 6480464 | Rotenone inhibits the reaction [Fructose results in increased expression of HMGCR mRNA] | CTD | PMID:21212096 |
| selenium atom | multiple interactions | ISO | RGD:2803 | 6480464 | Selenium promotes the reaction [Cholesterol results in decreased expression of HMGCR mRNA] | CTD | PMID:16581047 |
| simvastatin | increases expression | ISO | RGD:2803 | 6480464 | Simvastatin results in increased expression of HMGCR protein | CTD | PMID:12518039 |
| simvastatin | increases expression | ISO | RGD:2803 | 6480464 | Simvastatin results in increased expression of HMGCR mRNA | CTD | PMID:12056585 more ... |
| simvastatin | multiple interactions | ISO | RGD:2803 | 6480464 | resveratrol inhibits the reaction [Simvastatin results in increased expression of HMGCR mRNA]; more ... | CTD | PMID:21907337 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of HMGCR mRNA | CTD | PMID:10357840 more ... |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of HMGCR mRNA | CTD | PMID:9512650 more ... |
| simvastatin | increases expression | ISO | RGD:731580 | 6480464 | Simvastatin results in increased expression of HMGCR mRNA | CTD | PMID:22120639 PMID:16282522 |
| simvastatin | increases activity | ISO | RGD:2803 | 6480464 | Simvastatin results in increased activity of HMGCR protein | CTD | PMID:12056585 PMID:1627634 |
| simvastatin | decreases activity | EXP | | 6480464 | Simvastatin results in decreased activity of HMGCR protein | CTD | PMID:17980884 PMID:8593127 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of HMGCR mRNA | CTD | PMID:19383813 more ... |
| simvastatin | increases expression | ISO | RGD:2803 | 6480464 | Simvastatin results in increased expression of HMGCR mRNA | CTD | PMID:1627634 PMID:12056585 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of HMGCR mRNA | CTD | PMID:1627634 more ... |
| simvastatin | decreases activity | EXP | | 6480464 | Simvastatin results in decreased activity of HMGCR protein | CTD | PMID:8593127 PMID:17980884 |
| simvastatin | multiple interactions | EXP | | 6480464 | [HMGCR intron polymorphism affects the expression of HMGCR exon alternative form] which results in decreased susceptibility to Simvastatin | CTD | PMID:18559695 PMID:18559695 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of HMGCR mRNA | CTD | PMID:8517861 more ... |
| simvastatin | affects response to substance | EXP | | 6480464 | HMGCR polymorphism affects the susceptibility to Simvastatin | CTD | PMID:18332269 PMID:20413733 |
| simvastatin | increases activity | EXP | | 6480464 | Simvastatin results in increased activity of HMGCR protein | CTD | PMID:1627634 |
| simvastatin | decreases activity | EXP | | 6480464 | Simvastatin results in decreased activity of HMGCR protein | CTD | PMID:17980884 |
| simvastatin | multiple interactions | EXP | | 6480464 | [Simvastatin co-treated with ezetimibe] results in increased expression of HMGCR mRNA | CTD | PMID:17980884 |
| simvastatin | multiple interactions | EXP | | 6480464 | HMGCR polymorphism promotes the reaction [[LDLR 3' UTR polymorphism affects the susceptibility to Simvastatin] which affects the expression of APOB] | CTD | PMID:20413733 |
| simvastatin | affects response to substance | EXP | | 6480464 | HMGCR polymorphism affects the susceptibility to Simvastatin | CTD | PMID:20413733 PMID:18332269 |
| simvastatin | affects response to substance | EXP | | 6480464 | HMGCR intron polymorphism affects the susceptibility to Simvastatin | CTD | PMID:17870053 |
| simvastatin | multiple interactions | EXP | | 6480464 | [HMGCR intron polymorphism affects the expression of HMGCR exon alternative form] which results in decreased susceptibility to Simvastatin | CTD | PMID:18559695 |
| simvastatin | decreases response to substance | EXP | | 6480464 | HMGCR exon alternative form results in decreased susceptibility to Simvastatin | CTD | PMID:18559695 |
| simvastatin | increases expression | ISO | RGD:2803 | 6480464 | Simvastatin results in increased expression of HMGCR mRNA | CTD | PMID:12056585 PMID:1627634 |
| simvastatin | multiple interactions | ISO | RGD:2803 | 6480464 | Simvastatin results in increased expression of and results in increased activity of HMGCR protein | CTD | PMID:9512650 |
| simvastatin | increases activity | ISO | RGD:2803 | 6480464 | Simvastatin results in increased activity of HMGCR protein | CTD | PMID:1627634 PMID:12056585 |
| simvastatin | multiple interactions | ISO | RGD:2803 | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin results in increased activity of HMGCR protein]; more ... | CTD | PMID:12056585 |
| simvastatin | increases expression | ISO | RGD:731580 | 6480464 | Simvastatin results in increased expression of HMGCR mRNA | CTD | PMID:16282522 PMID:22120639 |
| simvastatin | multiple interactions | ISO | RGD:731580 | 6480464 | colesevelam promotes the reaction [Simvastatin results in increased expression of HMGCR mRNA] | CTD | PMID:22120639 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of HMGCR mRNA | CTD | PMID:17980884 more ... |
| simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin results in increased expression of and results in increased activity of HMGCR protein | CTD | PMID:9512650 |
| sirolimus | increases expression | EXP | | 6480464 | Sirolimus results in increased expression of HMGCR mRNA | CTD | PMID:17516993 |
| streptozocin | multiple interactions | ISO | RGD:2803 | 6480464 | Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in increased activity of HMGCR protein]; more ... | CTD | PMID:20696151 |
| tamoxifen | affects expression | ISO | RGD:731580 | 6480464 | Tamoxifen affects the expression of HMGCR mRNA | CTD | PMID:20937368 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of HMGCR mRNA | CTD | PMID:12414654 |
| testosterone | increases expression | ISO | RGD:731580 | 6480464 | Testosterone results in increased expression of HMGCR mRNA | CTD | PMID:16579987 |
| tetracycline | decreases expression | ISO | RGD:2803 | 6480464 | Tetracycline results in decreased expression of HMGCR mRNA | CTD | PMID:19224547 |
| tetrahydrocurcumin | multiple interactions | ISO | RGD:2803 | 6480464 | [tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in increased activity of HMGCR protein]; more ... | CTD | PMID:20696151 |
| thiourea | multiple interactions | ISO | RGD:2803 | 6480464 | Thiourea inhibits the reaction [Benzo(a)pyrene results in decreased expression of HMGCR mRNA]; more ... | CTD | PMID:19931295 |
| trans-4-coumaric acid | decreases expression | ISO | RGD:731580 | 6480464 | 4-coumaric acid results in decreased expression of HMGCR mRNA | CTD | PMID:21870829 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of HMGCR mRNA | CTD | PMID:22153697 |
| trans-resveratrol | decreases expression | ISO | RGD:2803 | 6480464 | resveratrol results in decreased expression of HMGCR mRNA | CTD | PMID:21907337 |
| trans-resveratrol | multiple interactions | ISO | RGD:2803 | 6480464 | resveratrol inhibits the reaction [Simvastatin results in increased expression of HMGCR mRNA]; more ... | CTD | PMID:21907337 |
| trans-resveratrol | decreases activity | ISO | RGD:731580 | 6480464 | resveratrol results in decreased activity of HMGCR protein | CTD | PMID:18611391 |
| trimellitic anhydride | increases expression | ISO | RGD:731580 | 6480464 | trimellitic anhydride results in increased expression of HMGCR mRNA | CTD | PMID:19042947 |
| triolein | increases expression | ISO | RGD:731580 | 6480464 | Triolein results in increased expression of HMGCR mRNA | CTD | PMID:18356535 |
| troglitazone | multiple interactions | EXP | | 6480464 | [[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of HMGCR mRNA | CTD | PMID:16946405 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of HMGCR mRNA | CTD | PMID:12044893 |
| troglitazone | increases activity | EXP | | 6480464 | troglitazone results in increased activity of HMGCR protein | CTD | PMID:12044893 |
| troglitazone | multiple interactions | EXP | | 6480464 | [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of HMGCR mRNA | CTD | PMID:12044893 |
| undecane | decreases expression | ISO | RGD:2803 | 6480464 | undecane results in decreased expression of HMGCR protein | CTD | PMID:17337753 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of HMGCR mRNA | CTD | PMID:19566492 |
| valproic acid | decreases expression | ISO | RGD:731580 | 6480464 | Valproic Acid results in decreased expression of HMGCR mRNA | CTD | PMID:22045034 |
| zinc atom | affects expression | ISO | RGD:2803 | 6480464 | Zinc affects the expression of HMGCR mRNA | CTD | PMID:17181878 |
| zinc atom | decreases expression | ISO | RGD:2803 | 6480464 | Zinc deficiency results in decreased expression of HMGCR mRNA | CTD | PMID:15671213 |
| zinc atom | decreases expression | ISO | RGD:2803 | 6480464 | Zinc results in decreased expression of HMGCR mRNA | CTD | PMID:17074742 |
| zinc sulfate | decreases expression | ISO | RGD:2803 | 6480464 | Zinc Sulfate results in decreased expression of HMGCR mRNA | CTD | PMID:17074742 |
| zinc(0) | affects expression | ISO | RGD:2803 | 6480464 | Zinc affects the expression of HMGCR mRNA | CTD | PMID:17181878 |
| zinc(0) | decreases expression | ISO | RGD:2803 | 6480464 | Zinc deficiency results in decreased expression of HMGCR mRNA | CTD | PMID:15671213 |
| zinc(0) | decreases expression | ISO | RGD:2803 | 6480464 | Zinc results in decreased expression of HMGCR mRNA | CTD | PMID:17074742 |
| ziprasidone | increases expression | EXP | | 6480464 | ziprasidone results in increased expression of HMGCR mRNA | CTD | PMID:17052361 |